Read Time:1 Minute, 5 Second
By MRCTV, Special for USDR.
Pregnant girls as young as 14 may participate in a study – without their parents’ approval – that measures how much they bleed, with and without an anti-hemorrhagic drug, after late-term abortions.
The “Effects of Oxytocin on Bleeding Outcomes During Dilation and Evacuation” clinical trial will measure what happens as the drug is, or is not, administered to women after a second-trimester abortion. The drug oxytocin causes uterine contracting and is commonly administered after a live birth to make sure that the woman does not bleed out.
A “double-blind, placebo controlled trial” means that a potentially lifesaving drug may be withheld to test what happens, warns radiologist Dr. Grazie Pozo Christie.
“This study is reminiscent of Nazi concentration camp experiments. I pity the poor women who are being treated like lab rats, especially those who are denied the drug to reduce hemorrhaging,” said Troy Newman
, President of Operation Rescue. “If there is a danger, the possibility of bleeding out, then why allow a 14-year-old to go through a double-blind placebo test?” asked Dr. Grazie Pozo Christie.